Sfoglia per Autore
Risk of infection in patients with multiple myeloma treated with T-cell redirecting approaches: a call out for clinicians
2024-01-01 Lupia, Tommaso; Cani, Lorenzo; Bringhen, Sara; De Rosa, Francesco Giuseppe; Bruno, Benedetto; Mikulska, Malgorzata; Corcione, Silvia; Mina, Roberto
Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience
2023-01-01 Mingrone, Giulia; Astarita, Anna; Colomba, Anna; Catarinella, Cinzia; Cesareo, Marco; Airale, Lorenzo; Paladino, Arianna; Leone, Dario; Vallelonga, Fabrizio; Bringhen, Sara; Gay, Francesca; Veglio, Franco; Milan, Alberto
Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study
2023-01-01 Astarita, Anna; Mingrone, Giulia; Airale, Lorenzo; Cesareo, Marco; Colomba, Anna; Catarinella, Cinzia; Leone, Dario; Gay, Francesca; Bringhen, Sara; Veglio, Franco; Milan, Alberto; Vallelonga, Fabrizio
The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review
2023-01-01 Mian, Hira; McCurdy, Arleigh; Giri, Smith; Grant, Shakira; Rochwerg, Bram; Winks, Erica; Rosko, Ashley E; Engelhardt, Monika; Pawlyn, Charlotte; Cook, Gordon; Jackson, Graham; Bringhen, Sara; Facon, Thierry; Larocca, Alessandra; Zweegman, Sonja; Wildes, Tanya M
Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma
2022-01-01 Bonello F.; Rocchi S.; Barila G.; Sandrone M.; Talarico M.; Zamagni E.; Scaldaferri M.; Vedovato S.; Bertiond C.; Pavan L.; Bringhen S.; Cattel F.; Zambello R.; Cavo M.; Mina R.
Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant
2022-01-01 Giaccone L.; Brunello L.; Londono J.S.; Scaldaferri M.; Cerrano M.; Redoglia V.; Omede P.; Lia G.; Massaia M.; Ferrero D.; Cavallo F.; Bringhen S.; Leone S.; Cattel F.; Francisci T.; Tassi V.; Evangelista A.; Boccadoro M.; Bruno B.
Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network
2021-01-01 Ludwig H.; Boccadoro M.; Moreau P.; San-Miguel J.; Cavo M.; Pawlyn C.; Zweegman S.; Facon T.; Driessen C.; Hajek R.; Dimopoulos M.A.; Gay F.; Avet-Loiseau H.; Terpos E.; Zojer N.; Mohty M.; Mateos M.-V.; Einsele H.; Delforge M.; Caers J.; Weisel K.; Jackson G.; Garderet L.; Engelhardt M.; van de Donk N.; Leleu X.; Goldschmidt H.; Beksac M.; Nijhof I.; Abildgaard N.; Bringhen S.; Sonneveld P.
Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial
2021-01-01 Mina R.; Falcone A.P.; Bringhen S.; Liberati A.M.; Pescosta N.; Petrucci M.T.; Ciccone G.; Capra A.; Patriarca F.; Rota-Scalabrini D.; Bonello F.; Musolino C.; Cea M.; Zambello R.; Tacchetti P.; Belotti A.; Cellini C.; Paris L.; Grasso M.; Aquino S.; De Paoli L.; De Sabbata G.; Ballanti S.; Offidani M.; Boccadoro M.; Monaco F.; Corradini P.; Larocca A.
Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies
2021-01-01 Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara
A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma
2021-01-01 Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P.
The role of monoclonal antibodies in the first-line treatment of transplant-ineligible patients with newly diagnosed multiple myeloma
2021-01-01 Bonello F.; Grasso M.; D'agostino M.; Celeghini I.; Castellino A.; Boccadoro M.; Bringhen S.
Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients
2021-01-01 Mingrone, Giulia; Astarita, Anna; Airale, Lorenzo; Maffei, Ilaria; Cesareo, Marco; Crea, Teresa; Bruno, Giulia; Leone, Dario; Avenatti, Eleonora; Catarinella, Cinzia; Salvini, Marco; Cetani, Giusy; Gay, Francesca; Bringhen, Sara; Veglio, Franco; Vallelonga, Fabrizio; Milan, Alberto
Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score
2021-01-01 D'Agostino M.; Larocca A.; Offidani M.; Liberati A.M.; Gaidano G.; Petrucci M.T.; Derudas D.; Capra A.; Zambello R.; Cascavilla N.; de Fabritiis P.; Innao V.; Bonello F.; Patriarca F.; Benevolo G.; Giuliani N.; Aitoro G.; Guglielmelli T.; Di Raimondo F.; Corradini P.; Musto P.; Hajek R.; Sonneveld P.; Boccadoro M.; Bringhen S.
Multiple myeloma patients undergoing carfilzomib: Development and validation of a risk score for cardiovascular adverse events prediction
2021-01-01 Astarita A.; Mingrone G.; Airale L.; Vallelonga F.; Covella M.; Catarinella C.; Cesareo M.; Bruno G.; Leone D.; Giordana C.; Cetani G.; Salvini M.; Gay F.; Bringhen S.; Rabbia F.; Veglio F.; Milan A.
Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma
2021-01-01 Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara
Ultra-Low-Dose Whole-Body Computed Tomography Protocol Optimization for Patients With Plasma Cell Disorders: Diagnostic Accuracy and Effective Dose Analysis From a Reference Center
2021-01-01 Tore D.; Rampado O.; Guarnaccia C.; Mina R.; Oronzio M.; Santonocito A.; Serafini A.; Strazzarino G.A.; Gianusso L.; Bringhen S.; Fonio P.; Depaoli A.
Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma
2020-01-01 Mateos, María-Victoria; Bladé, Joan; Bringhen, Sara; Ocio, Enrique M; Efebera, Yvonne; Pour, Luděk; Gay, Francesca; Sonneveld, Pieter; Gullbo, Joachim; Richardson, Paul G
Monoclonal antibodies to treat multiple myeloma: A dream come true
2020-01-01 D'Agostino M.; Innorcia S.; Boccadoro M.; Bringhen S.
Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing
2020-01-01 D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca
First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials
2020-01-01 Larocca, Alessandra; Mina, Roberto; Offidani, Massimo; Liberati, Anna Marina; Ledda, Antonio; Patriarca, Francesca; Evangelista, Andrea; Spada, Stefano; Benevolo, Giulia; Oddolo, Daniela; Innao, Vanessa; Cangialosi, Clotilde; Bernardini, Annalisa; Musto, Pellegrino; Amico, Valeria; Fraticelli, Vincenzo; Paris, Laura; Giuliani, Nicola; Falcone, Antonietta Pia; Zambello, Renato; De Paoli, Lorenzo; Romano, Alessandra; Palumbo, Antonio; Montefusco, Vittorio; Hajek, Roman; Boccadoro, Mario; Bringhen, Sara
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Risk of infection in patients with multiple myeloma treated with T-cell redirecting approaches: a call out for clinicians | 2024 | Lupia, Tommaso; Cani, Lorenzo; Bringhen, Sara; De Rosa, Francesco Giuseppe; Bruno, Benedetto; Mikulska, Malgorzata; Corcione, Silvia; Mina, Roberto | |
| Patients with Very High Risk of Cardiovascular Adverse Events during Carfilzomib Therapy: Prevention and Management of Events in a Single Center Experience | 2023 | Mingrone, Giulia; Astarita, Anna; Colomba, Anna; Catarinella, Cinzia; Cesareo, Marco; Airale, Lorenzo; Paladino, Arianna; Leone, Dario; Vallelonga, Fabrizio; Bringhen, Sara; Gay, Francesca; Veglio, Franco; Milan, Alberto | |
| Carfilzomib-Based Regimen and Cardiotoxicity in Multiple Myeloma: Incidence of Cardiovascular Events and Organ Damage in Carfilzomib-Dexamethasone versus Carfilzomib-Lenalidomide-Dexamethasone. A Real-Life Prospective Study | 2023 | Astarita, Anna; Mingrone, Giulia; Airale, Lorenzo; Cesareo, Marco; Colomba, Anna; Catarinella, Cinzia; Leone, Dario; Gay, Francesca; Bringhen, Sara; Veglio, Franco; Milan, Alberto; Vallelonga, Fabrizio | |
| The prevalence and outcomes of frail older adults in clinical trials in multiple myeloma: A systematic review | 2023 | Mian, Hira; McCurdy, Arleigh; Giri, Smith; Grant, Shakira; Rochwerg, Bram; Winks, Erica; Rosko, Ashley E; Engelhardt, Monika; Pawlyn, Charlotte; Cook, Gordon; Jackson, Graham; Bringhen, Sara; Facon, Thierry; Larocca, Alessandra; Zweegman, Sonja; Wildes, Tanya M | |
| Safety of Rapid Daratumumab Infusion: A Retrospective, Multicenter, Real-Life Analysis on 134 Patients With Multiple Myeloma | 2022 | Bonello F.; Rocchi S.; Barila G.; Sandrone M.; Talarico M.; Zamagni E.; Scaldaferri M.; Vedovato S.; Bertiond C.; Pavan L.; Bringhen S.; Cattel F.; Zambello R.; Cavo M.; Mina R. | |
| Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant | 2022 | Giaccone L.; Brunello L.; Londono J.S.; Scaldaferri M.; Cerrano M.; Redoglia V.; Omede P.; Lia G.; Massaia M.; Ferrero D.; Cavallo F.; Bringhen S.; Leone S.; Cattel F.; Francisci T.; Tassi V.; Evangelista A.; Boccadoro M.; Bruno B. | |
| Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network | 2021 | Ludwig H.; Boccadoro M.; Moreau P.; San-Miguel J.; Cavo M.; Pawlyn C.; Zweegman S.; Facon T.; Driessen C.; Hajek R.; Dimopoulos M.A.; Gay F.; Avet-Loiseau H.; Terpos E.; Zojer N.; Mohty M.; Mateos M.-V.; Einsele H.; Delforge M.; Caers J.; Weisel K.; Jackson G.; Garderet L.; Engelhardt M.; van de Donk N.; Leleu X.; Goldschmidt H.; Beksac M.; Nijhof I.; Abildgaard N.; Bringhen S.; Sonneveld P. | |
| Ixazomib-based induction regimens plus ixazomib maintenance in transplant-ineligible, newly diagnosed multiple myeloma: the phase II, multi-arm, randomized UNITO-EMN10 trial | 2021 | Mina R.; Falcone A.P.; Bringhen S.; Liberati A.M.; Pescosta N.; Petrucci M.T.; Ciccone G.; Capra A.; Patriarca F.; Rota-Scalabrini D.; Bonello F.; Musolino C.; Cea M.; Zambello R.; Tacchetti P.; Belotti A.; Cellini C.; Paris L.; Grasso M.; Aquino S.; De Paoli L.; De Sabbata G.; Ballanti S.; Offidani M.; Boccadoro M.; Monaco F.; Corradini P.; Larocca A. | |
| Carfilzomib, cyclophosphamide and dexamethasone for newly diagnosed, high-risk myeloma patients not eligible for transplant: a pooled analysis of two studies | 2021 | Mina, Roberto; Bonello, Francesca; Petrucci, Maria Teresa; Liberati, Anna Marina; Conticello, Concetta; Ballanti, Stelvio; Musto, Pellegrino; Olivieri, Attilio; Benevolo, Giulia; Capra, Andrea; Gilestro, Milena; Galieni, Piero; Cavo, Michele; Siniscalchi, Agostina; Palumbo, Antonio; Montefusco, Vittorio; Gaidano, Gianluca; Omedé, Paola; Boccadoro, Mario; Bringhen, Sara | |
| A longitudinal analysis of chromosomal abnormalities in disease progression from MGUS/SMM to newly diagnosed and relapsed multiple myeloma | 2021 | Oliva S.; De Paoli L.; Ruggeri M.; Caltagirone S.; Troia R.; Oddolo D.; D'Agostino M.; Gilestro M.; Mina R.; Saraci E.; Margiotta Casaluci G.; Genuardi E.; Bringhen S.; Boccadoro M.; Omede P. | |
| The role of monoclonal antibodies in the first-line treatment of transplant-ineligible patients with newly diagnosed multiple myeloma | 2021 | Bonello F.; Grasso M.; D'agostino M.; Celeghini I.; Castellino A.; Boccadoro M.; Bringhen S. | |
| Effects of Carfilzomib Therapy on Left Ventricular Function in Multiple Myeloma Patients | 2021 | Mingrone, Giulia; Astarita, Anna; Airale, Lorenzo; Maffei, Ilaria; Cesareo, Marco; Crea, Teresa; Bruno, Giulia; Leone, Dario; Avenatti, Eleonora; Catarinella, Cinzia; Salvini, Marco; Cetani, Giusy; Gay, Francesca; Bringhen, Sara; Veglio, Franco; Vallelonga, Fabrizio; Milan, Alberto | |
| Octogenarian newly diagnosed multiple myeloma patients without geriatric impairments: the role of age >80 in the IMWG frailty score | 2021 | D'Agostino M.; Larocca A.; Offidani M.; Liberati A.M.; Gaidano G.; Petrucci M.T.; Derudas D.; Capra A.; Zambello R.; Cascavilla N.; de Fabritiis P.; Innao V.; Bonello F.; Patriarca F.; Benevolo G.; Giuliani N.; Aitoro G.; Guglielmelli T.; Di Raimondo F.; Corradini P.; Musto P.; Hajek R.; Sonneveld P.; Boccadoro M.; Bringhen S. | |
| Multiple myeloma patients undergoing carfilzomib: Development and validation of a risk score for cardiovascular adverse events prediction | 2021 | Astarita A.; Mingrone G.; Airale L.; Vallelonga F.; Covella M.; Catarinella C.; Cesareo M.; Bruno G.; Leone D.; Giordana C.; Cetani G.; Salvini M.; Gay F.; Bringhen S.; Rabbia F.; Veglio F.; Milan A. | |
| Dose/schedule-adjusted Rd-R vs continuous Rd for elderly, intermediate-fit patients with newly diagnosed multiple myeloma | 2021 | Larocca, Alessandra; Bonello, Francesca; Gaidano, Gianluca; D'Agostino, Mattia; Offidani, Massimo; Cascavilla, Nicola; Capra, Andrea; Benevolo, Giulia; Tosi, Patrizia; Galli, Monica; Marasca, Roberto; Giuliani, Nicola; Bernardini, Annalisa; Antonioli, Elisabetta; Rota-Scalabrini, Delia; Cellini, Claudia; Pompa, Alessandra; Monaco, Federico; Patriarca, Francesca; Caravita di Toritto, Tommaso; Corradini, Paolo; Tacchetti, Paola; Boccadoro, Mario; Bringhen, Sara | |
| Ultra-Low-Dose Whole-Body Computed Tomography Protocol Optimization for Patients With Plasma Cell Disorders: Diagnostic Accuracy and Effective Dose Analysis From a Reference Center | 2021 | Tore D.; Rampado O.; Guarnaccia C.; Mina R.; Oronzio M.; Santonocito A.; Serafini A.; Strazzarino G.A.; Gianusso L.; Bringhen S.; Fonio P.; Depaoli A. | |
| Melflufen: A Peptide-Drug Conjugate for the Treatment of Multiple Myeloma | 2020 | Mateos, María-Victoria; Bladé, Joan; Bringhen, Sara; Ocio, Enrique M; Efebera, Yvonne; Pour, Luděk; Gay, Francesca; Sonneveld, Pieter; Gullbo, Joachim; Richardson, Paul G | |
| Monoclonal antibodies to treat multiple myeloma: A dream come true | 2020 | D'Agostino M.; Innorcia S.; Boccadoro M.; Bringhen S. | |
| Early Relapse Risk in Patients with Newly Diagnosed Multiple Myeloma Characterized by Next-generation Sequencing | 2020 | D'Agostino, Mattia; Zaccaria, Gian Maria; Ziccheddu, Bachisio; Rustad, Even H; Genuardi, Elisa; Capra, Andrea; Oliva, Stefania; Auclair, Daniel; Yesil, Jennifer; Colucci, Paola; Keats, Jonathan J; Gambella, Manuela; Bringhen, Sara; Larocca, Alessandra; Boccadoro, Mario; Bolli, Niccolò; Maura, Francesco; Gay, Francesca | |
| First-line therapy with either bortezomib-melphalan-prednisone or lenalidomide-dexamethasone followed by lenalidomide for transplant-ineligible multiple myeloma patients: a pooled analysis of two randomized trials | 2020 | Larocca, Alessandra; Mina, Roberto; Offidani, Massimo; Liberati, Anna Marina; Ledda, Antonio; Patriarca, Francesca; Evangelista, Andrea; Spada, Stefano; Benevolo, Giulia; Oddolo, Daniela; Innao, Vanessa; Cangialosi, Clotilde; Bernardini, Annalisa; Musto, Pellegrino; Amico, Valeria; Fraticelli, Vincenzo; Paris, Laura; Giuliani, Nicola; Falcone, Antonietta Pia; Zambello, Renato; De Paoli, Lorenzo; Romano, Alessandra; Palumbo, Antonio; Montefusco, Vittorio; Hajek, Roman; Boccadoro, Mario; Bringhen, Sara |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile